NCT03829852View on ClinicalTrials.gov

Regorafenib in Taiwan Metastatic Colorectal Cancer (mCRC) Patients

CompletedOBSERVATIONAL
Enrollment

716

Participants

Timeline

Start Date

February 11, 2019

Primary Completion Date

December 8, 2020

Study Completion Date

December 8, 2020

Conditions
Metastatic Colorectal Cancer
Interventions
DRUG

Regorafenib

Treatment was performed based on physician's discretion

Trial Locations (1)

Unknown

Taipei Veterans General Hospital, Taipei

All Listed Sponsors
collaborator

Chang Gung Memorial Hospital

OTHER

collaborator

Koo Foundation Sun Yat-Sen Cancer Center

OTHER

lead

Taipei Veterans General Hospital, Taiwan

OTHER_GOV

NCT03829852 - Regorafenib in Taiwan Metastatic Colorectal Cancer (mCRC) Patients | Biotech Hunter | Biotech Hunter